Has the Bridge Between Regulatory and HTA Agencies Collapsed? Adapting to the Avalanche Unvalidated Surrogate Outcomes in Early Stage Cancer Trials

Speaker(s)

Robert Bick, PhD, CanCertainty, Markham, ON, Canada

This Discussion Group will focus on and feature speakers from the session Has the Bridge Between Regulatory and HTA Agencies Collapsed? Adapting to the Avalanche Unvalidated Surrogate Outcomes in Early Stage Cancer Trials (Monday, May 8, 10:15am – 11:15am)

Seating is limited.

Code

118

Topic

Clinical Outcomes